[Ornithine transcarbamylase deficiency in adolescence and adulthood: first manifestation with life-threatening decompensation]
- PMID: 19468698
- DOI: 10.1007/s00101-009-1540-1
[Ornithine transcarbamylase deficiency in adolescence and adulthood: first manifestation with life-threatening decompensation]
Abstract
Background: Ornithine transcarbamylase (OTC) deficiency is the most frequent innate disorder of the urea cycle and is X-chromosome linked. The disease normally manifests itself shortly after birth and is fatal when untreated. Due to the different expression and X-chromosomal inheritance the manifestation of symptoms can appear later particularly in girls and young women. The first symptoms are non-specific signs of elevated cerebral pressure as a result of a hyperammonemia, which range from nausea and headache up to cerebral herniation with fatal outcome. Measurement of plasma ammonia levels is a simple yet important screening test for patients with unexpected stupor or delirium.
Case reports: The two case reports show the clinical range from acute decompensation with acute cerebral herniation followed by fatal outcome to recovery under emergency therapy without substantial neurological deficits.
Therapy: Emergency treatment consists of symptomatic securing of vital parameters and an immediate reduction in the ammonia level using high calorie, protein-free nutrition to avoid catabolism together with administration of arginine, benzoate or phenyl butyrate. In cases of coma with severe cerebral edema and the threat of a herniation reaction or excessive ammonia levels, emergency hemodialysis must be immediately carried out.
Conclusions: In the clinical routine it is extremely important to consider a metabolic defect at an early phase and among others to determine the ammonia level so that the appropriate treatment can be instigated in time.
Similar articles
-
Prenatal treatment of ornithine transcarbamylase deficiency.Mol Genet Metab. 2018 Mar;123(3):297-300. doi: 10.1016/j.ymgme.2018.01.004. Epub 2018 Jan 16. Mol Genet Metab. 2018. PMID: 29396029
-
Successful early management of a female patient with a metabolic stroke due to ornithine transcarbamylase deficiency.Pediatr Emerg Care. 2013 May;29(5):656-8. doi: 10.1097/PEC.0b013e31828ec2b9. Pediatr Emerg Care. 2013. PMID: 23640148
-
Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.Pediatr Crit Care Med. 2006 May;7(3):273-6. doi: 10.1097/01.PCC.0000216682.56067.23. Pediatr Crit Care Med. 2006. PMID: 16575347
-
Comprehensive characterization of ureagenesis in the spfash mouse, a model of human ornithine transcarbamylase deficiency, reveals age-dependency of ammonia detoxification.J Inherit Metab Dis. 2019 Nov;42(6):1064-1076. doi: 10.1002/jimd.12068. Epub 2019 Mar 13. J Inherit Metab Dis. 2019. PMID: 30714172 Review.
-
The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.Liver Transpl Surg. 1998 Sep;4(5):350-4. doi: 10.1002/lt.500040504. Liver Transpl Surg. 1998. PMID: 9724471 Review.
Cited by
-
Early warning signs in misrecognized secondary pediatric psychotic disorders: a systematic review.Eur Child Adolesc Psychiatry. 2019 Sep;28(9):1159-1167. doi: 10.1007/s00787-018-1208-y. Epub 2018 Jul 27. Eur Child Adolesc Psychiatry. 2019. PMID: 30054738
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical